ImmunoCellular proposes follow-on

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date announced: 2014-12-12 Type: Follow-on To be raised: Up to $20 million Shares: TBD Price prior: $0.85 Underwriter...